Skip to main content
Livermore
Livermore
ZHEN

Group One Trading, L.P.

SEC CIK
0000932540
Latest filing
Aug 13, 2026

IOVA holding history

Iovance Biotherapeutics, Inc. in every 13F filed by Group One Trading, L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IOVA overviewAll 13F holders of IOVAFull Q2 2026 holdings

Shares (Q2 2026)
237,671
Value
$988.7K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of IOVA by Group One Trading, L.P., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026237,671$988.7K<0.1%−358,085−60.1%ReducedHolders
Q1 2026595,756$2.09M0.1%+427,079+253.2%AddedHolders
Q4 2025168,677$460.5K<0.1%−261,177−60.8%ReducedHolders
Q3 2025429,854$932.8K<0.1%−123,614−22.3%ReducedHolders
Q2 2025553,468$952.0K<0.1%+77,667+16.3%AddedHolders
Q1 2025475,801$1.58M0.1%−1,220,500−72.0%ReducedHolders
Q4 20241,696,301$12.6M0.4%+413,333+32.2%AddedHolders
Q3 20241,282,968$12.0M0.5%+551,361+75.4%AddedHolders
Q2 2024731,607$5.87M0.2%+243,569+49.9%AddedHolders
Q1 2024488,038$7.23M0.3%−88,264−15.3%ReducedHolders
Q4 2023576,302$4.69M0.1%−49,399−7.9%ReducedHolders
Q3 2023625,701$2.85M0.1%+523,723+513.6%AddedHolders
Q2 2023101,978$717.9K<0.1%+41,747+69.3%AddedHolders
Q1 202360,231$368.0K<0.1%−70,444−53.9%ReducedHolders
Q4 2022130,675$835.0K<0.1%+65,137+99.4%AddedHolders
Q3 202265,538$628.0K<0.1%−54,984−45.6%ReducedHolders
Q2 2022120,522$1.33M<0.1%+119,451+11,153.2%AddedHolders
Q1 20221,071$18.0K<0.1%−31,864−96.7%ReducedHolders
Q4 202132,935$629.0K<0.1%−126,809−79.4%ReducedHolders
Q3 2021159,744$3.94M0.1%+159,744NewHolders
Q2 20210$00.0%−14,035−100.0%Sold outHolders
Q1 202114,035$444.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.